Using contrast-enhanced digital mammography (CEDM) to evaluate low to moderately suspicious breast lesions can greatly reduce biopsies in patients with benign lesions, according to a study published Sept. 5 in Academic Radiology.

Patients with a family or personal history of allergic reactions to contrast media are in danger of experiencing future reactions, according to a study published Sept. 3 in Radiology.  

Using [68Ga]Ga-PSMA-11 PET/CT to monitor treatment response in prostate cancer patients can offer important lesion-based insights over prostate-specific membrane antigen (PSMA)-based monitoring, according to a new study published in EJNMMI Research.

Providing patients more testing choices does not increase their participation in colorectal cancer screening—but the way clinician’s framed those choices did, according to a new study published in JAMA Network Open.

The Department of Energy (DOE)’s National Nuclear Security Administration has issued a fourth, and final, cooperative agreement to Corvallis, Oregon-based Northwest Medical Isotopes, LLC.

Trenton T. Kellock, MD, with Royal Inland Hospital’s Department of Medical Imaging in British Columbia, Canada, and colleagues performed a systematic review and meta-analysis of studies including more than 1,200 patients.

In July, SHINE was one of three companies to receive $15 million in funding from the Department of Energy (DOE)’s National Nuclear Security Administration to bolster its production of molybdenum-99 (Mo-99).

The Penn PET Addiction Center of Excellence (PACE) will harness the minds of radiology and psychiatry researchers to better understand opioid use disorder and develop improvement treatment options.